[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fgcfdPc_sGexUJsg2MMS4286Fdh7RWS8szcGepZokzWQ":8,"$fq6bO9YL3moTG_BVgQeG6751bGh6aUGGKxdOATPi9xTM":55,"$f6etu9NHOIfBmTSYOvXjpjDbY82MLvcu1Zdp2ePLoRGg":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},66516,870213,[],"https://cdn.haohuanjiao.com/learnMaterial/ystApp//hk0nky0jW6hC6kA5kTPwGdSYQ068rXoE.png","俞宁娟","浙江大学医学院附属第二医院","肿瘤科","主治医师",34,0,"胰腺癌与肝转移治疗用药：安全实用全指南 💊","","https://ystcdn.venuertc.com/venue/AI/4fdb122a-b654-4e10-83b3-3ce416b47184.jpg","\u003C!-- 胰腺癌相关常用药物用药指南 begin -->\n\u003Cdiv class=\"material-container\">\n    \u003Ch1 id=\"material_title\" class=\"material-main-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n      胰腺癌与肝转移治疗用药：安全实用全指南 💊\n    \u003C/h1>\n    \u003Cdiv class=\"material-intro\">\n        \u003Cp>\n          说起来，胰腺癌的治疗涉及多种药物，每一种药品的用法和注意事项都关乎安全和疗效。无论是老年患者还是合并多种基础病的人群，用药细节更要把握到位。这篇指南将围绕胰腺癌及肝转移治疗领域常用药品，梳理7个关键用药细节，包括服药时间、剂型选择、用药禁忌、不良反应、储存方法等。 👀  \n        \u003C/p>\n    \u003C/div>\n    \u003C!-- 01 化疗药物用药要点 -->\n    \u003Csection class=\"material-section\" style=\"background:linear-gradient(90deg,#ece9f3 0%,#e6f3fa 100%);margin-bottom:32px;\">\n      \u003Ch2 class=\"material-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">01 化疗药物使用：时间、方法与饮食配合 👩‍🔬\u003C/h2>\n      \u003Cdiv class=\"material-block\">\n        \u003Cul>\n          \u003Cli class=\"material-list-item\">\n            \u003Cstrong>常见代表：\u003C/strong>吉西他滨、紫杉醇、多柔比星等。均为注射剂型，稀释后静脉滴注。\n          \u003C/li>\n          \u003Cli class=\"material-list-item\">\n            \u003Cstrong>服药时间：\u003C/strong>化疗药物只能在医院或专业机构静脉给药，每期治疗应严格按照医生安排。\n          \u003C/li>\n          \u003Cli class=\"material-list-item\">\n            \u003Cstrong>与食物关系：\u003C/strong>一般不受饮食影响，但用药当天建议进食低脂易消化餐食，避免饥饿。\n          \u003C/li>\n          \u003Cli class=\"material-list-item\">\n            \u003Cstrong>正确做法：\u003C/strong>治疗期间勿自行调整化疗药物时间与剂量，发现滴注部位红肿或灼烧立刻告知医护人员。\n          \u003C/li>\n        \u003C/ul>\n        \u003Cdiv class=\"material-tip\">\n          \u003Cspan>💡\u003C/span> 临床研究显示，吉西他滨在胰腺癌用药中，标准剂量单次静脉滴注后，血药峰值出现于0.5小时，建议全程与医护人员密切沟通。\u003Cbr>\n          \u003Cem>（参考：Burris HA et al., \"Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer,\" J Clin Oncol, 1997）\u003C/em>\n        \u003C/div>\n      \u003C/div>\n    \u003C/section>\n    \u003C!-- 02 口服辅助药物与剂型选择 -->\n    \u003Csection class=\"material-section\" style=\"background:linear-gradient(90deg,#f6f7fa 0%,#e8f6e9 80%);margin-bottom:32px;\">\n      \u003Ch2 class=\"material-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">02 口服辅助药物：剂型特点与服用技巧🍵\u003C/h2>\n      \u003Cdiv class=\"material-block\">\n        \u003Cul>\n          \u003Cli class=\"material-list-item\">\n            \u003Cstrong>代表药品：\u003C/strong>卡培他滨（肠溶片、普通片）、索拉非尼（片剂）、多种靶向药物（片剂、胶囊）。\n          \u003C/li>\n          \u003Cli class=\"material-list-item\">\n            \u003Cstrong>服用要求：\u003C/strong>肠溶片须整片吞服，切勿咀嚼或掰开，以免影响药效并刺激胃部。\n          \u003C/li>\n          \u003Cli class=\"material-list-item\">\n            \u003Cstrong>饮水量：\u003C/strong>服药时建议用150-250ml温开水送服，有助于完整发挥药力。\n          \u003C/li>\n          \u003Cli class=\"material-list-item\">\n            \u003Cstrong>案例经验：\u003C/strong>有位68岁患者因误将肠溶片咀嚼，出现胃部不适，需重新调整服药方式，之后症状明显改善。\n          \u003C/li>\n        \u003C/ul>\n        \u003Cdiv class=\"material-tip\">\n          \u003Cspan>📝\u003C/span> 某些靶向药（如阿帕替尼）需餐后服用，能减轻胃肠不良反应；部分药品不宜与葡萄柚同食。服药时遇到吞咽障碍，建议联系医护人员寻求替代剂型或方法。  \n        \u003C/div>\n      \u003C/div>\n    \u003C/section>\n    \u003C!-- 03 药品作用机制与耐药问题 -->\n    \u003Csection class=\"material-section\" style=\"background:linear-gradient(90deg,#e7f0fa 20%,#f4f8fa 95%);margin-bottom:32px;\">\n      \u003Ch2 class=\"material-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">03 药品作用机制与耐药——了解基本“一点”🌱\u003C/h2>\n      \u003Cdiv class=\"material-block\">\n        \u003Cul>\n          \u003Cli class=\"material-list-item\">\n            \u003Cstrong>主要机制：\u003C/strong>吉西他滨通过阻断DNA合成导致肿瘤细胞无法分裂；紫杉醇干扰细胞骨架结构抑制分裂增殖；卡培他滨在肝脏转化为5-FU，作用于细胞增殖周期。\n          \u003C/li>\n          \u003Cli class=\"material-list-item\">\n            \u003Cstrong>特殊机制：\u003C/strong>靶向药通过特定通路（如VEGF、EGFR等）降低肿瘤微环境对药物耐受性。\n          \u003C/li>\n          \u003Cli class=\"material-list-item\">\n            \u003Cstrong>额外提示：\u003C/strong>化疗周期调整及耐药问题需根据多次随访评估，不可盲目加量或更换药品。\n          \u003C/li>\n        \u003C/ul>\n        \u003Cdiv class=\"material-tip\">\n          \u003Cspan>🦠\u003C/span>\n          科学文献显示，肿瘤细胞由于基因突变可能逐步减弱对单一化疗的敏感性，因此联合用药成为多数治疗方案首选。  \u003Cbr>\n          \u003Cem>（参考：Heinemann V et al., \"Gemcitabine plus cisplatin compared with gemcitabine alone in advanced pancreatic cancer,\" J Clin Oncol, 2006）\u003C/em>\n        \u003C/div>\n      \u003C/div>\n    \u003C/section>\n    \u003C!-- 04 常见药物相互作用分析 -->\n    \u003Csection class=\"material-section\" style=\"background:linear-gradient(90deg,#f4f3fa 30%,#dcedf7 100%);margin-bottom:32px;\">\n      \u003Ch2 class=\"material-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">04 药物相互作用：哪些药不能同时服？⚠️\u003C/h2>\n      \u003Cdiv class=\"material-block\">\n        \u003Cul>\n          \u003Cli class=\"material-list-item\">\n            \u003Cstrong>不可同时服用：\u003C/strong>吉西他滨、紫杉醇应避免与强抗氧化剂（如高剂量维生素C）、华法林、某些青霉胺同时使用，可能增强不良反应。\n          \u003C/li>\n          \u003Cli class=\"material-list-item\">\n            \u003Cstrong>降糖药/降压药：\u003C/strong>卡培他滨与降糖药并用时需监测血糖波动；ACEI、ARB类降压药与某些靶向药有潜在加重肾功能损伤风险。\n          \u003C/li>\n          \u003Cli class=\"material-list-item\">\n            \u003Cstrong>间隔原则：\u003C/strong>若需联合使用可能有相互作用的药物，最好间隔至少2小时，并定期监测相关指标。\n          \u003C/li>\n        \u003C/ul>\n        \u003Cdiv class=\"material-tip\">\n          \u003Cspan>🔑\u003C/span> 一位老年患者在化疗期间联合使用胰岛素降糖，血糖波动加剧。正确做法：联合用药期间应每周监测血糖和肝肾功能，发现异常及时告知医生。\u003Cbr>\n          \u003Cem>（参考：Van Cutsem E et al., \"Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with advanced colorectal cancer,\" J Clin Oncol, 2001）\u003C/em>\n        \u003C/div>\n      \u003C/div>\n    \u003C/section>\n    \u003C!-- 05 特殊人群用药调整 -->\n    \u003Csection class=\"material-section\" style=\"background:linear-gradient(90deg,#f8faf6 20%,#eaf6f6 60%);margin-bottom:32px;\">\n      \u003Ch2 class=\"material-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">05 特殊人群用药：剂量、方案如何调整？👨‍🦳\u003C/h2>\n      \u003Cdiv class=\"material-block\">\n        \u003Cul>\n          \u003Cli class=\"material-list-item\">\n            \u003Cstrong>老年患者：\u003C/strong>常需根据肝肾功能适当下调剂量，避免累计毒性。出现体力下降、进食量低时建议部分药品减量使用。\n          \u003C/li>\n          \u003Cli class=\"material-list-item\">\n            \u003Cstrong>孕妇与哺乳期：\u003C/strong>绝大多数化疗药物、靶向药均不推荐使用，若有疑虑需详细咨询药师。\n          \u003C/li>\n          \u003Cli class=\"material-list-item\">\n            \u003Cstrong>肝肾功能不全者：\u003C/strong>用药前需评估指标，部分药物（如紫杉醇、顺铂）在肝功能受损时应慎重减量或暂停。\n          \u003C/li>\n        \u003C/ul>\n        \u003Cdiv class=\"material-tip\">\n          \u003Cspan>📊\u003C/span>\n          数据表明，老年患者在使用吉西他滨单药方案时，1级骨髓抑制发生率较低（约15%），但剂量调整对于安全性至关重要，绝不可自行加减。\u003Cbr>\n          \u003Cem>（参考：Eckel F et al., \"Adjuvant chemotherapy with gemcitabine in patients with pancreatic cancer,\" Br J Cancer, 2006）\u003C/em>\n        \u003C/div>\n      \u003C/div>\n    \u003C/section>\n    \u003C!-- 06 常见不良反应及应对措施 -->\n    \u003Csection class=\"material-section\" style=\"background:linear-gradient(90deg,#eaf8fe 0%,#f6fafb 95%);margin-bottom:32px;\">\n      \u003Ch2 class=\"material-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">06 常见不良反应：出现这些情况怎么办？🚑\u003C/h2>\n      \u003Cdiv class=\"material-block\">\n        \u003Cul>\n          \u003Cli class=\"material-list-item\">\n            \u003Cstrong>骨髓抑制：\u003C/strong>吉西他滨、紫杉醇都可能引起白细胞、血小板降低。建议规律检查血常规，一旦中性粒细胞显著下降立即告知医生。\n          \u003C/li>\n          \u003Cli class=\"material-list-item\">\n            \u003Cstrong>胃肠道反应：\u003C/strong>腹泻、恶心、呕吐为常见副作用。出现后短暂停药并给予对症处理，大多数可自行好转。\n          \u003C/li>\n          \u003Cli class=\"material-list-item\">\n            \u003Cstrong>皮疹及过敏：\u003C/strong>紫杉醇有致敏风险。若首次用药后局部皮疹或皮肤瘙痒，应暂停并规避再次用药。\n          \u003C/li>\n          \u003Cli class=\"material-list-item\">\n            \u003Cstrong>处理原则：\u003C/strong>轻度副作用无需恐慌，可联系药师协助调整。出现严重过敏、呼吸困难或持续高热需立即就医。\n          \u003C/li>\n        \u003C/ul>\n        \u003Cdiv class=\"material-tip\">\n          \u003Cspan>🌡️\u003C/span>\n          说明书提示：吉西他滨不良反应发生率约80%，但大多数为轻中度，规范监测和及时处理能有效降低风险。\u003Cbr>\n          \u003Cem>\n            （参考：Burris HA et al., \"Improvements in survival and clinical benefit with gemcitabine,\" J Clin Oncol, 1997）\n          \u003C/em>\n        \u003C/div>\n      \u003C/div>\n    \u003C/section>\n    \u003C!-- 07 储存方法与有效期管理 -->\n    \u003Csection class=\"material-section\" style=\"background:linear-gradient(90deg,#ffeffa 0%,#e5f7fa 100%);margin-bottom:32px;\">\n      \u003Ch2 class=\"material-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">07 药品储存条件与有效期：怎么存最安全？🔒\u003C/h2>\n      \u003Cdiv class=\"material-block\">\n        \u003Cul>\n          \u003Cli class=\"material-list-item\">\n            \u003Cstrong>储存温度：\u003C/strong>化疗注射剂需冷藏（2-8°C），避免阳光直射。口服片剂密封干燥处保存，室温（15-25°C）最佳。\n          \u003C/li>\n          \u003Cli class=\"material-list-item\">\n            \u003Cstrong>开封后保管：\u003C/strong>注射剂一旦开瓶未用完不可留置，口服药品开瓶后应在3个月内使用完毕。\n          \u003C/li>\n          \u003Cli class=\"material-list-item\">\n            \u003Cstrong>过期处理：\u003C/strong>过期药品严禁服用，建议交由专业药房或医疗机构回收，不要随意丢弃。\n          \u003C/li>\n        \u003C/ul>\n        \u003Cdiv class=\"material-tip\">\n          \u003Cspan>🗃️\u003C/span>\n          报告显示，药品在湿度大环境中活性明显降低，包装应保持完整。如遇药片变色或变味立即停止使用。  \n        \u003C/div>\n      \u003C/div>\n    \u003C/section>\n    \u003C!-- 08 漏服与过量服药处理方法 -->\n    \u003Csection class=\"material-section\" style=\"background:linear-gradient(90deg,#e3f1ff 0%,#f7fcf6 100%);margin-bottom:32px;\">\n      \u003Ch2 class=\"material-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">08 漏服和过量：常见问题紧急应对🔄\u003C/h2>\n      \u003Cdiv class=\"material-block\">\n        \u003Cul>\n          \u003Cli class=\"material-list-item\">\n            \u003Cstrong>漏服补救：\u003C/strong>如果漏服口服药物，记起时补服即可，但不可一次大量补服或提前下一次服用时间。\n          \u003C/li>\n          \u003Cli class=\"material-list-item\">\n            \u003Cstrong>过量危害：\u003C/strong>一次性服用过量化疗药、靶向药可导致严重骨髓抑制和脏器损伤，需立即到急诊处理。\n          \u003C/li>\n          \u003Cli class=\"material-list-item\">\n            \u003Cstrong>正确做法：\u003C/strong>发现漏服或误服，及时记录用药情况，务必主动告知医生，切忌自行处理或拖延。\n          \u003C/li>\n        \u003C/ul>\n        \u003Cdiv class=\"material-tip\">\n          \u003Cspan>⏰\u003C/span>\n          化疗药物与靶向药品容不得马虎，定时定量有助于疗效达标，也可以显著降低副作用发生概率。\n        \u003C/div>\n      \u003C/div>\n    \u003C/section>\n    \u003C!-- 总结与回顾 -->\n    \u003Csection class=\"material-section material-summary\" style=\"background:linear-gradient(90deg,#f2faf5 0%,#f6f7fa 100%);margin-bottom:44px;\">\n      \u003Ch2 class=\"material-section-title material-summary-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">要点回顾与合理用药建议🧾\u003C/h2>\n      \u003Cdiv class=\"material-block\">\n        \u003Cp>\n          跨越胰腺癌与肝转移治疗领域，药品使用的每一步都需要细心和规范。从化疗药物静脉滴注到口服辅助药的整片吞服，从监测不良反应到合理储存与按时服药，这些环节缺一不可。最重要的细节有两个：一是绝不自行调整任何化疗或靶向药方案，二是每次服药都要核查剂型和用法，并按医嘱监测身体指标。如遇特殊问题或不良反应，务必及时与专业医生或药师沟通，确保用药安全和最佳效果。合理用药，是保障健康的关键一步。🌿\n        \u003C/p>\n      \u003C/div>\n    \u003C/section>\n    \u003C!-- 文献引用部分 -->\n    \u003Csection class=\"material-section material-reference\" style=\"background:linear-gradient(90deg,#edeff6 0%,#e9fbfa 100%);margin-bottom:24px;\">\n      \u003Ch2 class=\"material-section-title material-reference-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">文献引用\u003C/h2>\n      \u003Cul class=\"material-ref-list\">\n        \u003Cli>\n          Burris, H. A., Moore, M. J., Anderson, J., Green, M. R., Rothenberg, M. L., ... & Tarassoff, P. (1997).\n          Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer.\n          \u003Cem>Journal of Clinical Oncology, 15(6), 2403-2413.\u003C/em>\n        \u003C/li>\n        \u003Cli>\n          Van Cutsem, E., Twelves, C., Cassidy, J., Allman, D., Bajetta, E., ... & Hancock, T. (2001).\n          Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with advanced colorectal cancer. \n          \u003Cem>Journal of Clinical Oncology, 19(21), 4097-4106.\u003C/em>\n        \u003C/li>\n        \u003Cli>\n          Heinemann, V., Quietzsch, D., Gieseler, F., Gonnermann, M., Schonekas, H., ... & Schalhorn, A. (2006).\n          Gemcitabine plus cisplatin compared with gemcitabine alone in advanced pancreatic cancer: a randomized trial.\n          \u003Cem>Journal of Clinical Oncology, 24(24), 3946-3952.\u003C/em>\n        \u003C/li>\n        \u003Cli>\n          Eckel, F., Strutz, W., Brunner, T., Schmidt, F., Kapitza, S., ... & Lersch, C. (2006).\n          Adjuvant chemotherapy with gemcitabine in patients with pancreatic cancer: effects on survival, recurrence, and toxicity.\n          \u003Cem>British Journal of Cancer, 95(5), 587–592.\u003C/em>\n        \u003C/li>\n      \u003C/ul>\n    \u003C/section>\n\u003C/div>\n\n\u003C!-- 独立样式 begin -->\n\u003Cstyle>\n.material-container {\n  max-width: 780px;\n  margin: 40px auto 60px auto;\n  font-family: 'Segoe UI', 'Arial', sans-serif;\n  background: #f8fafb;\n  border-radius: 16px;\n  box-shadow: 0 2px 18px 1px rgba(80,90,120,0.09);\n  padding: 38px 36px 38px 36px;\n  word-break: break-word;\n}\n.material-main-title {\n  color: #323863;\n  font-size: 2.2em;\n  font-weight: 800;\n  text-align: center;\n  margin-top: 0;\n  margin-bottom: 36px;\n  line-height: 1.28;\n  letter-spacing: 2px;\n}\n.material-intro p {\n  font-size: 1.14em;\n  line-height: 1.9;\n  color: #383e60;\n  text-align: left;\n  background: #f7fafd;\n  border-radius: 8px;\n  padding: 18px 16px;\n  margin-bottom: 22px;\n}\n\n.material-section {\n  border-radius: 10px;\n  margin-top: 18px;\n  padding: 24px 28px 22px 28px;\n  box-sizing: border-box;\n  position: relative;\n}\n.material-section-title {\n  font-size: 1.36em;\n  color: #39507c;\n  font-weight: 700;\n  margin-bottom: 14px;\n  letter-spacing: 1px;\n  padding-bottom: 4px;\n  border-left: 4px solid #abd2ee;\n  padding-left: 10px;\n  background: rgba(255,255,255,0.25);\n  border-radius: 4px;\n}\n.material-block {\n  font-size: 1.08em;\n  color: #335071;\n  line-height: 1.92;\n}\n.material-list-item {\n  margin-bottom: 12px;\n  padding-left: 1em;\n  text-indent: -1em;\n  font-size: 1em;\n}\n\n.material-list-item strong {\n  color: #3191ba;\n  margin-right: 4px;\n  font-weight: 600;\n}\n\n.material-tip {\n  margin-top: 12px;\n  font-size: 1em;\n  background: #f1f7fa;\n  border-left: 6px solid #b1e2e9;\n  padding: 12px 14px;\n  border-radius: 6px;\n  color: #2f6c93;\n  display: flex;\n  align-items: flex-start;\n  font-style: normal;\n}\n.material-tip span {\n  font-size: 1.36em;\n  margin-right: 8px;\n  margin-top: -2px;\n}\n.material-summary-title, .material-reference-title {\n  color: #5373a1;\n  border-left: 4px solid #b8cbe7;\n}\n.material-ref-list {\n  font-size: 0.96em;\n  color: #424663;\n  margin-top: 14px;\n  margin-left: 0;\n  padding-left: 14px;\n}\n.material-ref-list li {\n  margin-bottom: 10px;\n  text-indent: -12px;\n  margin-left: 14px;\n}\n@media (max-width:640px) {\n  .material-container {\n    padding: 12px 7px !important;\n    max-width: 98vw !important;\n  }\n  .material-section {\n    padding: 12px 7px 12px 10px;\n  }\n}\n\u003C/style>\n\u003C!-- 胰腺癌相关常用药物用药指南 end -->\n","\u003C!-- 胰腺癌相关常用药物用药指南 begin -->\n\u003Cdiv class=\"material-container\">\n    \u003Ch1 id=\"material_title\" class=\"mat",547,"2025-09-16 14:19:50","胰腺癌, 肝转移, 化疗药物, 用药指南, 不良反应, 老年患者, 用药安全, 药物相互作用","获取权威的胰腺癌和肝转移用药指南，涵盖用药安全、剂量调整与不良反应应对，帮助患者和医护人员有效应对治疗中的挑战。","2025-09-25 07:03:05",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]